Is green tea good for HIV-1 infection?

Journal of Allergy and Clinical Immunology

Volumn 112, Issue 5, 2003, Pages 851-853

  Nance, Christina L ^a   Shearer, William T ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Catechins; CD4 HIV 1 binding domain; CD4 molecule; CD4 pocket for EGCG; Competitive inhibition; Conformational fit; Electron density map; Green tea; Protein databank

Indexed keywords

CATECHIN; CD4 ANTIGEN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GLYCOPROTEIN GP 120; GREEN TEA EXTRACT;

ANTIGEN STRUCTURE; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; CANCER INCIDENCE; EDITORIAL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; TEA;

EID: 0242719854     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2003.08.048     Document Type: Editorial

References (23)

1. Kwong P, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998;393:648-59.
2. Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, et al. Antibody neutralization and escape by HIV-1. Nature 2003;42:307-12.
3. Chinen J, Shearer WT. Molecular virology and immunology of HIV infection. J Allergy Clin Immunol 2002;110:189-98.
4. Sleasman JW, Goodenow MM. HIV-1 infection. J Allergy Clin Immunol 2003;111:S582-92.
5. Chinen J, Shearer WT. Immune-based therapies for HIV infection. In: Shearer WT, Hanson IC, editors. Medical management of AIDS in children. Philadelphia: WB Saunders; 2003. p. 139-54.
6. Kawai KN, Tsuno N, Kitayama J, Okaji Y, Yazawa K, Asakage M, et al. Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding. J Allergy Clin Immunol 2003;112:951-7.
7. Nakachi K, Matsuyama S, Miyake S, Suganuma M, Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 2000;134:49-54.
8. NCI, DCPC Chemoprevention branch and agent development committee. Clinical development plan: tea extracts, green tea polyphenols, epigallocatechin gallate. J Cell Biochem 1996;26:S236-57.
9. Okubo S, Hara Y, Mori F, Shimamura T. Bactericidal and anti-toxin activities of catechin on enterohemorrhagic Escherichia coli. J Jpn Assoc Infect Dis 1997;72:211-7.
10. Yamaguchi K, Honda M, Ikigai H, Hara Y, Shimamura T. Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Res 2002;53:19-34.
11. Nakane H, Ono K. Differential inhibition of HIV-reverse transcriptase and various DNA and RNA polymerases by some catechin derivatives. Nucleic Acids Research 1989;21:115-16.
12. Fassina G, Buffa A, Benelli R, Varnier OE, Noonan DM, Albinai A. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. AIDS 2002;16:939-41.
13. Zaveri N. Synthesis of a 3,4,5-trimethoxybenzoyl ester analogue of epigallocatchin-3-gallate (EGCG): a potential route to the natural product green tea catechin, EGCG. Organic Letters 2000;3:843-6.
14. Lee MJ, Maliakal P, Chen L, Meng X, Bondoc FY, Prabhu S, et al. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epi Bio Prev 2002;11:1025-32.
15. Kohlmeier L, Weterings KG, Steck S, Kok FJ. Tea and cancer prevention: an evaluation of the epidemiologic literature. Nutr Cancer 1997;27:1-13.
16. Maeda-Yamamoto M, Kawahara H, Tahara N, Tsuji K, Hara Y, Isemura M. Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells. J Agric Food Chem 1999;47:2350-4.
17. Sartippour M, Shao Z, Heber D, Beatty P, Zhang L, Liu C, et al. Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J Nutr 2002;132:2307-11.
18. Arthos J, Deen KC, Chaikin MA, Fornwald JA, Sathe G, Sattentau QJ, et al. Identification of the residues in human CD4 critical for the binding of HIV. Cell 1989;57:469-81.
19. Ho DD, McKeating JA, Li XL, Moudgil T, Daar ES, Sun NC, et al. Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. J Virol 1991;65:489-93.
20. Wu H, Myszka DG, Tendian SW, Brouillette CG, Sweet RW, Chaiken IM, et al. Kinetic and structural analysis of mutant CD4 receptors that are defective in HIV gp120 binding. Proc Natl Acad Sci U S A 1996;93:15030-5.
21. Charlton A, Haslam E, Williamson M. Multiple conformations of the proline-rich protein/epigallocatechin gallate complex determined by time-averaged nuclear Overhauser effects. J Am Chem Soc 2002;124:9899-905.
22. Chow H, Cai Y, Alberts DS, Hakim I, Dorr R, Shahi F, et al. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatehin gallate and polyphenon E. Cancer Epi Bio Prev 2001;10:53-8.
23. Pisters KM, Newman RA, Coldman B, Shin DM, Khuri FR, Hong WK, et al. Phase 1 trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol 2001;19:1830-8.